The biochemical study of intermaxillary fixation (IMF) stress in oral surgery inpatients

Kurume Medical Journal

Volumn 48, Issue 1, 2001, Pages 71-77

  Sakaino, Hidenori ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

17 hydrocorticosteroids (17 OHCS); 17 ketosteroid (17 KS); Ethyl loflazepate; Intermaxillary fixation (IMF); Natural killer cell activity (NK activity); Stress

Indexed keywords

17 HYDROXYCORTICOSTEROID; 17 OXOSTEROID; ANXIOLYTIC AGENT; BENZODIAZEPINE; CORTICOSTERONE; DIAZEPAM; ETHYL LOFLAZEPATE; HYDROCORTISONE; NORADRENALIN;

ADULT; ARTICLE; BIOCHEMISTRY; CORTICOSTERONE BLOOD LEVEL; FEMALE; FRACTURE FIXATION; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MAXILLA FRACTURE; MECHANICAL STRESS; MENTAL IRRITATION; NATURAL KILLER CELL; NORADRENALIN RELEASE; ORAL SURGERY; SURGICAL STRESS;

EID: 0034989973     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.48.71     Document Type: Article

References (39)

1. Koga C, Emoto H, Tanaka M, and Kameyama T. Effect of intermaxillary fixation (IMF) on rat brain noradrenaline turnover. Jpn J Oral Maxillofac Surg 1992; 38:1059-1062. (in Japanese)
2. Koga C, Emoto H, Yokoo H, Ishii H, Yoshida M et al. Effect of irritable stress model (intermaxillary fixation) on the rat immunological system and brain noradrenaline turnover. J Brain Sci 1999; 25:1-7.
3. Koga C. The changes in noradrenaline release in the rat brain region caused by intermaxillary fixation (IMF) and their modifications by diazepam. J Kurume Med Assoc 1993; 56:145-157. (in Japanese)
4. Levy SM, and Herberman RB. Persistently low natural killer cell activity in normal adults: immunological, hormonal and mood correlates. Nat Immun Cell Growth Regul 1988; 8:173-186.
5. Pross HF, and Baines MG. Studies of human natural killer cells. In vivo parameters affecting normal cytotoxic function. Int J Cancer 1982; 29:383-390.
6. Masuda A, Nozoe S, Naruo T, Soejima Y, Nagai N et al. Natural killer cell activity in relation to psychobehavioral responses, stress coping behavior, and fatigue in healthy adult men. Jpn J Psychosom Med 1995; 35:383-390. (in Japanese)
7. Kusaka Y, and Morimoto K. Does lifestyle modulate natural killer cell activities? Jpn J Hyg 1992; 46:1035-1041. (in Japanese)
8. Nagao F, and Okumura K. Relation between stress and NK activity. J Clin Anesth 1997; 21:571-579.
9. Ohtani Y. A clinical study on natural killer (NK) cell activity in patients with cancer. J Jpn Soc Clin Surg 1983; 5:569-583. (in Japanese)
10. Tanabe K, Kinoshita Y, Tokuyoshi K, Houri D, Asagi K et al. Central nervous actions of ethyl loflazepate, a new benzodiazepine derivative. Yonago Acta Med 1982; 33:189-200. (in Japanese)
11. Mori A, Hata Y, Hasegawa K, Iwai H, Noguchi T et al. Clinical study on CM6912 (ethyl loflazepate) in treatment of neuroses. Jpn J Clin Psychiat 1986; 15:275-285. (in Japanese)
12. Koga C, Sakaino H, Fukuda K, and Kameyama T. Questionnaire investigation and biochemical examination about stress in intermaxillary fixation (IMF) patients. Jpn J Psychosom Dent 1996; 11:16-21. (in Japanese)
13. Kato T. 17-hydroxycorticosteroid (17-OHCS) and these fraction. Jpn J Clin Med 1985; 43 (A special Autumn issue): 896-901. (in Japanese)
14. Yakata M, and Sakurai A. Urinary 17-ketosteroid (17-KS) and these fraction. Jpn J Clin Med 1985; 43 (A special Autumn issue): 914-916. (in Japanese)
15. Nagel JE, Collins GD, and Adler WH. Spontaneous or natural killer cytotoxicity of K 562 erythroleukemic cells in normal patients. Cancer Res 1981; 41:2284-2288.
16. Yasu K, and Sawada S. Target cell cytotoxic test. Medical Technol 1993; 21:574-580.
17. Ichihara K. Statistics for Bioscience. Nankodo Co., Ltd., Tokyo, 1990.
18. Ozaki M. Analysis of variance. In: Stat View 5.0, A Perfect Guide to Master, Nankodo Co., Ltd., Tokyo, pp158-184, 1999.
19. Assael LA, and Tucker MR. Management of facial fractures. In: Contemporary Oral and Maxillofacial Surgery, ed. Peterson LJ, Mosby Co., UAS, pp557-576, 1988.
20. Selye H. A syndrome by diverse nocuous agents. Nature 1936; 138:32.
21. Glavin GB. Stress and brain noradrenaline: a review. Neurosci Biobehav Rev 1985; 9:233-243.
22. Tanaka M, Kohno Y, Nakagawa R, Ida Y, Iimori K et al. Time-related differences in noradrenaline turnover in rat brain regions by stress. Pharmacol Biochem Behav 1982; 16:315-319.
23. Glavin GB, Tanaka M, Tsuda A, Kohno Y, Hoaki Y et al. Regional rat brain noradrenaline turnover in response to restraint stress. Pharmacol Biochem Behav 1983; 19:287-290.
24. Iimori K, Tanaka M, Kohno Y, Ida Y, Nakagawa R et al. Psychological stress enhances noradrenaline turnover in specific brain regions in rats. Pharmacol Biochem Behav 1982; 16:637-640.
25. Nakagawa R, Tanaka M, Kohno Y, Noda Y, and Nagasaki N. Regional responses of rat brain noradrenergic neurones to acute intense stress. Pharmacol Biochem Behav 1981; 14:729-732.
26. Tanaka M, Kohno Y, Nakagawa R, Ida Y, Takada S et al. Regional characteristics of stress-induced increases in brain noradrenaline release in rats. Pharmacol Biochem Behav 1983; 19:543-547.
27. Tsuda A, Tanaka M, Ida Y, Shirao I, Gondoh Y et al. Expression of aggression attenuates stress-induced increases in rat brain noradrenaline turnover. Brain Res 1988; 474:174-180.
28. Emoto H, Koga C, Ishii H, Yokoo H, Yoshida M et al. A CRF antagonist attenuates stress-induced increases in NA turnover in extended brain regions in rats. Brain Res 1993;627:171-176.
29. Ganong WF. Neurotransmitter and pituitary function: regulation of ACTH secretion. Fed Proc 1980; 39:2923-2930.
30. Schedlowski M, and Schmidt RE. Stress and the immune system. Naturwissenschaften 1996; 83:214-220.
31. Abo T, Cooper MD, and Balch CM. Postnatal expansion of the natural killer and killer cell population in humans identified by the monoclonal HNK-1 antibody. J Exp Med 1982; 155:321-326.
32. Irwin M, Patterson T, Smith TL, Caldwell C, Brown SA et al. Reduction of immune function in life stress and depression. Biol Psychiatry 1990; 27:22-30.
33. Masuda A, Nozoe S, and Tanaka H. Psycho-behavioral responses and cellular immune function of adults, without any organic disorders, with chronic fatigue. Jpn J Psychosom Med 1993; 33:302-308. (in Japanese)
34. Mawle AC. Chronic fatigue syndrome. Immunol Invest 1997; 26:269-273.
35. Spiegel D. Cancer and depression. Br J Psychiatry (Suppl) 1996; 30:109-116.
36. Lesko LM. Supportive care and quality of life, psychological issues. Cancer: Principles & Practice of Oncology 1997; 5:2879-2891.
37. Sato K. Immunological study on reactivation of latency infected herpes simplex virus type-1 in relation to natural killer-cell activity. J Kurume Med Assoc 1997; 60:19-27. (in Japanese)
38. Nakagawa T, Noda T, Kimura M, Fukamachi K, Sakata T et al. Clinical evaluation of ethyl Loflazepate (CM6912), a new antianxiety drug, on psychosomatic disorders and neuroses in the fields of internal and psychosomatic medicine -with special regard to the utility of administering CM6912 once daily-. Jpn Pharmacol Ther 1986; 14:281-298. (in Japanese)
39. Olsen RW. GABA-benzodiazepine-barbiturate receptor interactions. J Neurochem 1981; 37:1-13.